91Indexed trials
Market Rank #26 · Evidence Tier A
Finland
Neuroscience Intelligence
Finland neuroscience intelligence: 91 indexed trials, 54 institutions, research score 35.79.
22Recruiting
54Research institutions
35.8Research score
Evidence profile
52Sponsors
18Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 35.8 · Data confidence 100.00 · Evidence 35.8
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
alzheimers22trials
parkinsons18trials
epilepsy14trials
stroke10trials
other_neurology4trials
depression4trials
schizophrenia4trials
other_psychiatry2trials
sleep_disorders2trials
pain_neuropathy2trials
Leading indexed sponsors
Merck Sharp & Dohme LLC9trials
Boehringer Ingelheim6trials
Hoffmann-La Roche6trials
Novartis Pharmaceuticals4trials
Helsinki University Central Hospital4trials
UCB Pharma3trials
Pfizer3trials
Orion Corporation, Orion Pharma3trials
Turku University Hospital3trials
Bristol-Myers Squibb2trials